Sleep Patterns in Children Aged 0-36 Months and Maternal Anxiety and Depression

March 12, 2026 updated by: Şeymanur Uçum, Başakşehir Çam & Sakura City Hospital

Maternal Anxiety and Depression and Their Association With Sleep Patterns in Children Aged 0-36 Months

In this study, the investigators aimed to investigate the relationship between the sleep patterns of children aged 0-36 months hospitalized in the general pediatrics clinic and their mothers' anxiety and depression levels.

Study Overview

Status

Completed

Conditions

Detailed Description

Sleep problems during infancy and early childhood are common and may affect both child development and family well-being. Maternal psychological status, particularly anxiety and depression, may play an important role in shaping infant sleep patterns through behavioral and environmental mechanisms. Understanding this relationship may help identify families at risk and contribute to early supportive interventions.

This observational study aims to investigate the relationship between sleep patterns of children aged 0-36 months and maternal anxiety and depression levels. Infant sleep characteristics, including total sleep duration, number of night awakenings, and sleep quality, will be assessed using the Brief Infant Sleep Questionnaire-Revised (BISQ-R) completed by mothers.

Maternal psychological status will be evaluated using validated psychological assessment tools. Maternal depression will be assessed using the Beck Depression Inventory (BDI), while maternal anxiety levels will be assessed using the Beck Anxiety Inventory (BAI).

The association between infant sleep parameters and maternal anxiety and depression scores will be analyzed to evaluate the potential relationship between maternal psychological status and infant sleep patterns in children aged 0-36 months. The findings of this study are expected to improve understanding of factors influencing sleep during early childhood and may help inform early supportive strategies for families.

Study Type

Observational

Enrollment (Actual)

110

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • İ̇stanbul
      • Başakşehir, İ̇stanbul, Turkey (Türkiye), 34107
        • Basaksehir Cam ve Sakura City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study includes children aged 0-36 months and their mothers. Children's sleep patterns were assessed using the Brief Infant Sleep Questionnaire (BISQ). Mothers' anxiety and depression levels were assessed using validated questionnaires (The Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI)). Participants were recruited from pediatric inpatient clinics.

Description

Inclusion Criteria:

  • Children aged 0-36 months hospitalized in the general pediatrics clinic and their mothers

Exclusion Criteria:

  • Outpatients,
  • Newborns aged 0-29 days,
  • Patients over 3 years of age,
  • Infants diagnosed with chronic diseases,
  • Infants diagnosed sleep disorders,
  • Mothers diagnosed with psychiatric disorders,
  • Mothers receiving regular medical treatment for anxiety and depression disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hospitalized infants (0-36 months) and mothers
Single cohort of mother-infant dyads with infants aged 0-36 months hospitalized in the pediatric inpatient ward. Maternal anxiety and depressive symptoms were assessed using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). Infant sleep characteristics were assessed using the Brief Infant Sleep Questionnaire (BISQ). No intervention was administered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spearman Correlation Between Maternal Anxiety and Infant Sleep Status
Time Frame: single assessment at enrollment during inpatient hospitalization
Spearman correlation (rho) between maternal Beck Anxiety Inventory (BAI) total score (0-63 points) and infant total sleep duration (hours) assessed by the Brief Infant Sleep Questionnaire (BISQ) at enrollment during inpatient hospitalization. Unit of measure: Spearman rho (correlation coefficient).
single assessment at enrollment during inpatient hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation Between Maternal Depression and Infant Sleep Status
Time Frame: single assessment at enrollment during inpatient hospitalization
pearman correlation (rho) between maternal Beck Depression Inventory (BDI) total score (0-63 points) and infant total sleep duration (hours) assessed by BISQ at enrollment during inpatient hospitalization. Unit of measure: Spearman rho.
single assessment at enrollment during inpatient hospitalization
Maternal Anxiety Score by Infant Sleep Disorder Status
Time Frame: Baseline (single assessment at enrollment during inpatient hospitalization)
Comparison of maternal BAI total score (0-63 points) between infants with vs without BISQ-defined sleep disorder (>3 night awakenings OR >60 min nocturnal wakefulness OR <9 h total sleep duration) at enrollment during inpatient hospitalization. Unit of measure: BAI total scores.
Baseline (single assessment at enrollment during inpatient hospitalization)
Sleep Disorder Proportion by Maternal Sleep Satisfaction
Time Frame: Baseline (single assessment at enrollment during inpatient hospitalization)
Proportion of infants with BISQ-defined sleep disorder compared across maternal sleep satisfaction categories (very satisfied, moderately satisfied, not satisfied) assessed at enrollment during inpatient hospitalization. Unit of measure: % (proportion).
Baseline (single assessment at enrollment during inpatient hospitalization)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Başakşehir Çam & Sakura City Hospital

Investigators

  • Principal Investigator: Furkan ÇOLAK, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
  • Principal Investigator: Şeymanur UÇUM, MD, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 22, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Actual)

February 27, 2026

Study Registration Dates

First Submitted

March 9, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BCSSH-SBU-ŞU-12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Problems

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe